États-Unis · Bourse & Finance · Yahoo Finance

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

Publié par Yahoo Finance · États-Unis il y a 14 h

SAN CARLOS, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the pricing of concurrent underwritten public…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

À lire aussi

How Trump’s Tariff War With Canada Ensnared the Can-Am Spyder

Enliven, FDA agree on phase 3 trial design for relcobatinib for chronic myeloid leukemia

Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia

Bitcoin.de trading remains halted as German regulator rejects MiCA application

Everything we know about the suspected plague case in Russia so far

Former CIA official with Top Secret clearance admits to $194 million fraud, including 298 gold bars and four luxury South Florida properties

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

Partager

À lire aussi

How Trump’s Tariff War With Canada Ensnared the Can-Am Spyder

Enliven, FDA agree on phase 3 trial design for relcobatinib for chronic myeloid leukemia

Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia

Bitcoin.de trading remains halted as German regulator rejects MiCA application

Everything we know about the suspected plague case in Russia so far

Former CIA official with Top Secret clearance admits to $194 million fraud, including 298 gold bars and four luxury South Florida properties